Drug Trial Radar · NCT00005975
S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer
Last checked: Nov 20, 2026Latest source record: Nov 18, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
288
Actual
Start
Apr 1998
Primary completion
Sep 2001
Study completion Mar 2002
Sponsor
- Lead sponsor
- SWOG Cancer Research NetworkResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Jun 28, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Supportive care
- Who can join
- Female only, up to 120 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Megestrol may be effective in treating hot flashes following treatment for breast cancer. It is not yet known which regimen of megestrol is most effective for hot flashes. PURPOSE: Randomized phase III trial to compare the effectiveness of different doses of megestrol in treating hot flashes in patients who have undergone therapy for breast cancer.
Conditions
- Breast Cancer
- Hot Flashes
Interventions
Megestrol Acetate 20mg/dayDrug
Double blinded Megestrol Acetate 20 mg/day
Megestrol Acetate 40 mg/dayDrug
Double blinded Megestrol Acetate 40 mg/day
Megestrol Acetate Placebo 20 mg/dayDrug
Megestrol Acetate Placebo 20 mg/day
Megestrol Acetate Placebo 40 mg/dayDrug
Megestrol Acetate Placebo 40 mg/day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Effectiveness and duration of the benefit of placebo and 2 dose levels of megestrol acetate in reduction of severe and/or frequent hot flashes in patients with history of adequate local and regional treatment of invasive breast cancerTime frame: 3, 6, and 9 months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.